SCHEMBL27485938

SCHEMBL27485938

NCc1cccc(NC(=O)c2cccc(N)c2Cc2ccncc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 2/20 0.53
▸ AURKB Q96GD4 1/20 0.53
▸ KDR P35968 5/20 0.47
▸ MAPT P10636 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ CSF1R P07333 1/20 0.43
▸ PDGFRB P09619 1/20 0.43
▸ KIT P10721 1/20 0.43
▸ FLT1 P17948 1/20 0.43
▸ FLT4 P35916 1/20 0.43
▸ CYP17A1 P05093 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ FADS1 O60427 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467102 0.90 SMN1; SMN2 (0.54) PRKCIKDRMAPTSMN1; SMN2LMNA
SCHEMBL27468045 0.87 KDR (0.44) PRKCIKDRMAPTSMN1; SMN2ABL1
SCHEMBL27486254 0.87 SMN1; SMN2 (0.53) PRKCIKDRMAPTSMN1; SMN2LMNA
SCHEMBL27548625 0.86 KDR (0.59) KDRMAPTSMN1; SMN2FLT1FADS1
SCHEMBL27484538 0.86 CYP17A1 (0.56) KDRMAPTSMN1; SMN2ABL1EGFR
SCHEMBL27465575 0.86 P2RX1 (0.50) PRKCIKDRMAPTSMN1; SMN2ABL1
SCHEMBL27485249 0.86 MAPT (0.47) PRKCIKDRMAPTSMN1; SMN2CYP17A1
SCHEMBL27508410 0.85 KCNK3 (0.45) KDRMAPTSMN1; SMN2ABL1EGFR
SCHEMBL27484537 0.84 HTT (0.53) LMNA
SCHEMBL27466657 0.84 PTGS1 (0.64) KDRABL1EGFRCSF1RPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback